Showing results (811-820 of 1,524) with videos related to

Sort By:
Pageof 153
CPT: Pharmacometrics & Systems Pharmacology|September 17, 2024
Modeling serum M-protein response for early detection of biochemical relapse in myeloma patients treated with bortezomib, lenalidomide and dexamethasoneYuki Otani, Yunqi Zhao, Guanyu Wang, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 18, 2024
A close examination of BCRP's role in lactation and methods for predicting drug distribution into milkCaroline Sychterz, Hong Shen, Yueping Zhang, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 17, 2024
Uncovering the interleukin-12 pharmacokinetic desensitization mechanism and its consequences with mathematical modelingJonathon DeBonis, Omid Veiseh, Oleg A Igoshin
CPT: Pharmacometrics & Systems Pharmacology|November 7, 2024
An integrated quantitative systems pharmacology virtual population approach for calibration with oncology efficacy endpointsNathan Braniff, Tanvi Joshi, Tyler Cassidy, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 7, 2024
Population pharmacokinetic modeling of paired plasma-breast milk lamivudine data for estimation of infant exposure in breastfeeding mother-infant pairsFrancis Williams Ojara, Aida N Kawuma, Shadia Nakalema, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 28, 2024
Within-chain parallelization-Giving Stan Jet Fuel for population modeling in pharmacometricsCasey Davis, Pavan Vaddady
CPT: Pharmacometrics & Systems Pharmacology|November 5, 2024
Global sensitivity analysis of Open Systems Pharmacology Suite physiologically based pharmacokinetic modelsAbdulkarim Najjar, Abdullah Hamadeh, Sophia Krause, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 14, 2025
Intranasal diamorphine population pharmacokinetics modeling and simulation in pediatric breakthrough painLianjin Cai, Jingchen Zhai, Beihong Ji, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 12, 2025
Quantitative Systems Pharmacology Model to Predict Target Occupancy by Bruton Tyrosine Kinase Inhibitors in Patients With B-Cell MalignanciesOleg Demin, Ying Ou, Galina Kolesova, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 25, 2025
Model-Informed Drug Development of a Sustained Release Formulation of Flucytosine in the Treatment of Cryptococcal Meningitis: A Case Study Using Physiologically Based Pharmacokinetic ModelingJohanna Eriksson, Erik Sjögren, Jean-Yves Gillon, et al.
Pageof 153